IE782499L - Anticolinergics - Google Patents
AnticolinergicsInfo
- Publication number
- IE782499L IE782499L IE782499A IE249978A IE782499L IE 782499 L IE782499 L IE 782499L IE 782499 A IE782499 A IE 782499A IE 249978 A IE249978 A IE 249978A IE 782499 L IE782499 L IE 782499L
- Authority
- IE
- Ireland
- Prior art keywords
- atoms
- halogen
- image
- alkoxy
- attached form
- Prior art date
Links
- 125000004432 carbon atom Chemical group C* 0.000 abstract 6
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- 229910004679 ONO2 Inorganic materials 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000005041 acyloxyalkyl group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 230000001078 anti-cholinergic effect Effects 0.000 abstract 1
- 230000001262 anti-secretory effect Effects 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- -1 nitro, carboxyl Chemical group 0.000 abstract 1
- 150000003512 tertiary amines Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/90—Benzo [c] furans; Hydrogenated benzo [c] furans with an oxygen atom in position 1 and a nitrogen atom in position 3, or vice versa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Compounds of general formula I or II: <IMAGE> are disclosed, wherein <IMAGE> represents tertiary amine <IMAGE> an unsaturated amine and R2, R3 and R4 (which may be the same or different, but at least two of them must be other than H and together they must contain at least five C-atoms) each represents hydrogen, C1-C8 alkyl or alkoxy, cycloalkyl cycloalkenyl, alkoxyalkyl, acyloxyalkyl, haloalkyl or carboxyalkyl each having up to 8 C atoms, alkenylphenyl having unto 8 C-atoms in the alkenyl moiety, aryl (optionally substituted by halogen, C1-C4 alkoxy, acyloxy, nitro, carboxyl or carboethoxy), -CH2, -CH2OCOR1 (wherein R1 is as defined below or -CH2ONO2), -OH, halogen, -OCOR1 (wherein R1 is as defined below) or - ONO2; or R2 is as hereinbefore defined and R3, R4 and the carbon atoms to which they are attached form a cyclo-alkyl group having up to 8 carbon atoms, or the groups represented by R2, R3 and R4 and the carbon atom to which they are attached form a fused polycarbocylic ring or a polyheterocyclic ring; and R1 is as defined by R2, R3 or R4; X is -O- or -S- and Y is halogen or another anion. The compounds possess anticholinergic anti- secretory activity, while exhibiting low toxicity following therapeutic application.
[GB2010270A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86121077A | 1977-12-16 | 1977-12-16 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE782499L true IE782499L (en) | 1979-06-16 |
| IE48012B1 IE48012B1 (en) | 1984-09-05 |
Family
ID=25335183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE2499/78A IE48012B1 (en) | 1977-12-16 | 1978-12-18 | Soft anticholinergic agents exhibiting antisecretory activity |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS5498711A (en) |
| AR (1) | AR222478A1 (en) |
| AT (1) | AT366380B (en) |
| AU (1) | AU531835B2 (en) |
| CA (1) | CA1102345A (en) |
| DE (1) | DE2854308A1 (en) |
| DK (1) | DK534178A (en) |
| ES (1) | ES476048A1 (en) |
| FR (1) | FR2422624A1 (en) |
| GB (1) | GB2010270B (en) |
| IE (1) | IE48012B1 (en) |
| IT (1) | IT1101735B (en) |
| NL (1) | NL7812257A (en) |
| NO (1) | NO148776C (en) |
| SE (1) | SE436027B (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3045055A1 (en) * | 1980-11-29 | 1982-07-01 | Celamerck Gmbh & Co Kg, 6507 Ingelheim | HETEROCYCLIC COMPOUNDS |
| JPS5993075A (en) * | 1982-11-18 | 1984-05-29 | Shionogi & Co Ltd | Preparation of 1-phthalidyl-5-fluorouracil derivative |
| US5008111A (en) * | 1984-10-11 | 1991-04-16 | Schering Corporation | Physiological means of enhancing transdermal delivery of drugs |
| US4824676A (en) * | 1984-10-11 | 1989-04-25 | Schering Corporation | Physiological means of enhancing transdermal delivery of drugs |
| FR2703046B1 (en) * | 1993-03-26 | 1995-05-05 | Poudres & Explosifs Ste Nale | Process for the preparation of alpha-monohalogenated oxalates and haloglyoxalates and new alpha-monohalogenated oxalates and haloglyoxalates. |
| AUPN814496A0 (en) | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
| US5962505A (en) * | 1998-08-31 | 1999-10-05 | Bobrove; Arthur M. | Method for treating hot flashes in humans |
| US6433003B1 (en) | 1999-04-23 | 2002-08-13 | Arthur M. Bobrove | Method for treating hyperhidrosis in mammals |
| AR044134A1 (en) | 2003-05-02 | 2005-08-24 | Novartis Ag | DERIVATIVES OF QUINUCLIDINE, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS. |
| EP1896038B1 (en) | 2005-06-03 | 2016-11-09 | Acrux DDS Pty Ltd | Method and composition for testosterone transdermal delivery |
| WO2007077510A2 (en) * | 2005-12-30 | 2007-07-12 | Ranbaxy Laboratories Limited | Muscarinic receptor antagonists |
| KR101662186B1 (en) | 2007-11-02 | 2016-10-04 | 애크럭스 디디에스 피티와이 리미티드 | Transdermal delivery system |
| JP6621329B2 (en) * | 2012-10-05 | 2019-12-18 | スファエラ ファーマ ピーティーイー リミテッド | Novel compounds, their synthesis and their use |
| DE102013013397A1 (en) | 2013-08-13 | 2015-03-12 | Epinamics Gmbh | Aerosol dispenser for transdermal pharmaceutical compositions |
| CN110041264A (en) * | 2019-04-11 | 2019-07-23 | 贺州学院 | A kind of adamantyl glyoxaline ion liquid and preparation method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL101555C (en) * | 1955-03-19 | |||
| BE798253A (en) * | 1973-04-16 | 1973-10-16 | Bekaert Sa Nv | SEATING |
| US3998815A (en) * | 1974-06-24 | 1976-12-21 | Interx Research Corporation | 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts |
-
1978
- 1978-11-29 DK DK534178A patent/DK534178A/en not_active Application Discontinuation
- 1978-12-12 IT IT30735/78A patent/IT1101735B/en active
- 1978-12-15 AR AR274836A patent/AR222478A1/en active
- 1978-12-15 JP JP15601378A patent/JPS5498711A/en active Pending
- 1978-12-15 SE SE7812911A patent/SE436027B/en unknown
- 1978-12-15 NO NO784229A patent/NO148776C/en unknown
- 1978-12-15 DE DE19782854308 patent/DE2854308A1/en not_active Withdrawn
- 1978-12-15 ES ES476048A patent/ES476048A1/en not_active Expired
- 1978-12-18 AT AT0901478A patent/AT366380B/en active
- 1978-12-18 AU AU42646/78A patent/AU531835B2/en not_active Expired
- 1978-12-18 GB GB7848850A patent/GB2010270B/en not_active Expired
- 1978-12-18 CA CA318,112A patent/CA1102345A/en not_active Expired
- 1978-12-18 IE IE2499/78A patent/IE48012B1/en unknown
- 1978-12-18 FR FR7835596A patent/FR2422624A1/en active Granted
- 1978-12-18 NL NL7812257A patent/NL7812257A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SE436027B (en) | 1984-11-05 |
| FR2422624B1 (en) | 1983-10-14 |
| SE7812911L (en) | 1979-06-17 |
| DE2854308A1 (en) | 1979-06-21 |
| NL7812257A (en) | 1979-06-19 |
| AU4264678A (en) | 1979-06-21 |
| IT7830735A0 (en) | 1978-12-12 |
| JPS5498711A (en) | 1979-08-03 |
| NO784229L (en) | 1979-06-19 |
| GB2010270B (en) | 1982-10-20 |
| DK534178A (en) | 1979-06-17 |
| IE48012B1 (en) | 1984-09-05 |
| CA1102345A (en) | 1981-06-02 |
| FR2422624A1 (en) | 1979-11-09 |
| AR222478A1 (en) | 1981-05-29 |
| ES476048A1 (en) | 1979-11-01 |
| ATA901478A (en) | 1981-08-15 |
| AU531835B2 (en) | 1983-09-08 |
| NO148776B (en) | 1983-09-05 |
| NO148776C (en) | 1983-12-14 |
| GB2010270A (en) | 1979-06-27 |
| IT1101735B (en) | 1985-10-07 |
| AT366380B (en) | 1982-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES476048A1 (en) | Novel "soft" anticholinergic agents exhibiting anti-secretory activity | |
| ES8102107A1 (en) | Thiazolidine derivatives, preparing same and pharmaceutical compositions comprising same. | |
| SE8004783L (en) | DELTA? 722-1,2,4TRIAZOLIN-5-one derivatives | |
| IE46278L (en) | Tri-phenyl-substituted-piperazine derivatives | |
| ZA831633B (en) | New compounds,processes for their preparation and their use as medicaments | |
| IE780625L (en) | Imidazo-triazines | |
| ATE19074T1 (en) | OCTAHYDRONAPHTHALINE DERIVATIVES AND THEIR PRODUCTION. | |
| IE44265L (en) | Amino-alcohols | |
| ES8505942A1 (en) | 2-hydroxypropylamine aryl ester derivatives. | |
| ES488644A1 (en) | 1-Allyltriazole derivatives, process for their preparation and their use as plant protecting agents. | |
| IE41503L (en) | Pipeazinyl-benzimidazoles | |
| IE41244B1 (en) | Pyridobenzodiazepinones | |
| ATE27817T1 (en) | PHENYLPIPERAZINE DERIVATIVES AND PROCESS FOR THEIR MANUFACTURE. | |
| IE780718L (en) | Pyrroloquinoxalines | |
| ES2019552A6 (en) | Process for the preparation of glycerophospholipids | |
| IE45269L (en) | 8-hydroxy-5-(3-amino-2-hydroxypropoxy) carbostyrils | |
| IE780262L (en) | Carbocyclic fused thiophen-2-oxaminic acid derivatives | |
| IE892294L (en) | Cycloalkylthiazole derivatives | |
| IE780279L (en) | Imidazole derivatives | |
| IE45702L (en) | Pyridobenzodiazepinones | |
| IE802112L (en) | Pyridine derivatives. | |
| IE820464L (en) | Morpholines | |
| EP0133259A3 (en) | Aminoalkyl-substituted benzene derivatives, process for production thereof, and pharmaceutical composition thereof | |
| KR850700244A (en) | Cephalosporin derivatives and preparation methods thereof | |
| ES477709A1 (en) | Benzothiazepines |